Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Tuberculosis D014376 20 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Watson L et al. Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus. 2012 J. Clin. Immunol. pmid:22648459
Sato C et al. Sphingosine 1-phosphate receptor activation enhances BMP-2-induced osteoblast differentiation. 2012 Biochem. Biophys. Res. Commun. pmid:22659743
Farahat WA et al. Ensemble analysis of angiogenic growth in three-dimensional microfluidic cell cultures. 2012 PLoS ONE pmid:22662145
Nijnik A et al. The role of sphingosine-1-phosphate transporter Spns2 in immune system function. 2012 J. Immunol. pmid:22664872
Kunisawa J and Kiyono H Immunological function of sphingosine 1-phosphate in the intestine. 2012 Nutrients pmid:22666543
Yang J et al. Proximal cerebral arteries develop myogenic responsiveness in heart failure via tumor necrosis factor-α-dependent activation of sphingosine-1-phosphate signaling. 2012 Circulation pmid:22668972
Li C et al. Sphingosine 1-phosphate receptor 2 antagonist JTE-013 increases the excitability of sensory neurons independently of the receptor. 2012 J. Neurophysiol. pmid:22673325
Takuwa Y et al. Sphingosine-1-phosphate signaling in physiology and diseases. 2012 Sep-Oct Biofactors pmid:22674845
Shmyrev VI et al. [Sphingosine-1-phosphate signaling system and the innovative mechanism of action of fingolimod in treatment of multiple sclerosis: review of foreign literature]. 2012 Zh Nevrol Psikhiatr Im S S Korsakova pmid:22677684
Lee SH et al. Higher circulating sphingosine 1-phosphate levels are associated with lower bone mineral density and higher bone resorption marker in humans. 2012 J. Clin. Endocrinol. Metab. pmid:22679064
Ishii M and Kikuta J Sphingosine-1-phosphate signaling controlling osteoclasts and bone homeostasis. 2013 Biochim. Biophys. Acta pmid:22691949
Krishna SM et al. Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model. 2012 Am. J. Pathol. pmid:22698985
Ponnusamy S et al. Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis. 2012 EMBO Mol Med pmid:22707406
García-Bernal D et al. Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function. 2013 J. Pathol. pmid:22711564
Testai FD et al. Changes in the cerebrospinal fluid ceramide profile after subarachnoid hemorrhage. 2012 Stroke pmid:22713492
García-Merino JA and Sánchez AJ [Basic mechanisms of action of fingolimod in relation to multiple sclerosis]. 2012 Rev Neurol pmid:22718407
Hisano Y et al. Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells. 2012 PLoS ONE pmid:22723910
Upadhyaya P et al. The sphingolipid degradation product trans-2-hexadecenal forms adducts with DNA. 2012 Biochem. Biophys. Res. Commun. pmid:22727907
Chiba K and Yoshii N [Pharmacological properties and clinical efficacy of fingolimod hydrochloride (Imusera®/Gilenya®) for the treatment of multiple sclerosis]. 2012 Nippon Yakurigaku Zasshi pmid:22728990
Linke B et al. Analysis of sphingolipid and prostaglandin synthesis during zymosan-induced inflammation. 2012 Prostaglandins Other Lipid Mediat. pmid:22732087
Yokoyama K et al. Decrease of serum sphingosine-1-phosphate levels in hemodialysis patients with secondary hyperparathyroidism treated with cinacalcet. 2012 Clin. Nephrol. pmid:22732343
Ohotski J et al. Identification of novel functional and spatial associations between sphingosine kinase 1, sphingosine 1-phosphate receptors and other signaling proteins that affect prognostic outcome in estrogen receptor-positive breast cancer. 2013 Int. J. Cancer pmid:22733311
Takuwa Y et al. Sphingosine-1-phosphate as a mediator involved in development of fibrotic diseases. 2013 Biochim. Biophys. Acta pmid:22735357
Olivera A et al. Shaping the landscape: metabolic regulation of S1P gradients. 2013 Biochim. Biophys. Acta pmid:22735358
Karliner JS Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress. 2013 Biochim. Biophys. Acta pmid:22735359
Che W et al. Sphingosine 1-phosphate induces MKP-1 expression via p38 MAPK- and CREB-mediated pathways in airway smooth muscle cells. 2012 Biochim. Biophys. Acta pmid:22743041
Kharel Y et al. Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate. 2012 Biochem. J. pmid:22747486
Saba JD and de la Garza-Rodea AS S1P lyase in skeletal muscle regeneration and satellite cell activation: exposing the hidden lyase. 2013 Biochim. Biophys. Acta pmid:22750505
Zhang BL et al. Sphingosine 1-phosphate acts as an activator for the porcine Gpr3 of constitutively active G protein-coupled receptors. 2012 J Zhejiang Univ Sci B pmid:22761247
Kotelevets N et al. Targeting sphingosine kinase 1 in carcinoma cells decreases proliferation and survival by compromising PKC activity and cytokinesis. 2012 PLoS ONE pmid:22761740
Nakahara T et al. Sphingosine-1-phosphate inhibits H2O2-induced granulosa cell apoptosis via the PI3K/Akt signaling pathway. 2012 Fertil. Steril. pmid:22763095
Czarnota GJ et al. Tumor radiation response enhancement by acoustical stimulation of the vasculature. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22778441
Brizuela L et al. First evidence of sphingosine 1-phosphate lyase protein expression and activity downregulation in human neoplasm: implication for resistance to therapeutics in prostate cancer. 2012 Mol. Cancer Ther. pmid:22784711
Chan H and Pitson SM Post-translational regulation of sphingosine kinases. 2013 Biochim. Biophys. Acta pmid:22801036
Orr Gandy KA and Obeid LM Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors. 2013 Biochim. Biophys. Acta pmid:22801037
Pyne NJ et al. Role of sphingosine 1-phosphate and lysophosphatidic acid in fibrosis. 2013 Biochim. Biophys. Acta pmid:22801038
Shea BS and Tager AM Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis. 2012 Proc Am Thorac Soc pmid:22802282
Boussommier-Calleja A et al. Pharmacologic manipulation of conventional outflow facility in ex vivo mouse eyes. 2012 Invest. Ophthalmol. Vis. Sci. pmid:22807298
Iwaki S et al. Posttranscriptional regulation of expression of plasminogen activator inhibitor type-1 by sphingosine 1-phosphate in HepG2 liver cells. 2012 Nov-Dec Biochim. Biophys. Acta pmid:22819712
Knapp M et al. Myocardial infarction changes sphingolipid metabolism in the uninfarcted ventricular wall of the rat. 2012 Lipids pmid:22833182
Pitman MR et al. Molecular targets of FTY720 (fingolimod). 2012 Curr. Mol. Med. pmid:22834825
Liu Q et al. Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats. 2012 PLoS ONE pmid:22848628
Yu FX et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. 2012 Cell pmid:22863277
Curry FE et al. Erythrocyte-derived sphingosine-1-phosphate stabilizes basal hydraulic conductivity and solute permeability in rat microvessels. 2012 Am. J. Physiol. Heart Circ. Physiol. pmid:22865384
Donati C et al. New insights into the role of sphingosine 1-phosphate and lysophosphatidic acid in the regulation of skeletal muscle cell biology. 2013 Biochim. Biophys. Acta pmid:22877992
Kim BJ et al. Plasma sphingosine 1-phosphate levels and the risk of vertebral fracture in postmenopausal women. 2012 J. Clin. Endocrinol. Metab. pmid:22879631
Miller E et al. Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP. 2012 Chem. Biol. pmid:22884261
Asghar MY et al. Sphingosine 1-phosphate and human ether-a'-go-go-related gene potassium channels modulate migration in human anaplastic thyroid cancer cells. 2012 Endocr. Relat. Cancer pmid:22889737
Schwalm S et al. Sphingosine-1-phosphate: a Janus-faced mediator of fibrotic diseases. 2013 Biochim. Biophys. Acta pmid:22889995
Masuko K et al. Sphingosine-1-phosphate modulates expression of vascular endothelial growth factor in human articular chondrocytes: a possible new role in arthritis. 2012 Int J Rheum Dis pmid:22898216
Schmitz EI et al. Sphingosine 1-phosphate protects primary human keratinocytes from apoptosis via nitric oxide formation through the receptor subtype S1P₃. 2012 Mol. Cell. Biochem. pmid:22899173
Egom EE A therapeutic approach to hyperglycaemia in the setting of acute myocardial infarction: spotlight on glucagon-like peptide 1. 2012 Ther Adv Cardiovasc Dis pmid:22902834
Ihlefeld K et al. Evidence for a link between histone deacetylation and Ca²+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts. 2012 Biochem. J. pmid:22908849
Kimizuka K et al. Sphingosine 1-phosphate (S1P) induces S1P2 receptor-dependent tonic contraction in murine iliac lymph vessels. 2013 Microcirculation pmid:22913344
He S et al. Self-amplification mechanisms of mast cell activation: a new look in allergy. 2012 Curr. Mol. Med. pmid:22920722
Hisano Y et al. The functional roles of S1P in immunity. 2012 J. Biochem. pmid:22923732
Wang ZY et al. [Effect of sphingosine 1-phosphate/sphingosine 1-phosphate receptor signal pathway on function of neutrophils]. 2012 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:22931670
Price MM et al. A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell-dependent murine model of allergic asthma. 2013 J. Allergy Clin. Immunol. pmid:22939756
Jin YX et al. A strategy for enrichment of the bioactive sphingoid base-1-phosphates produced by Hypericum perforatum L. in a balloon type airlift reactor. 2012 Bioresour. Technol. pmid:22940331
Snider AJ et al. Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease. 2012 Prostaglandins Other Lipid Mediat. pmid:22940715
Cannon RE et al. Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22949658
Richerioux N et al. Rho-ROCK and Rac-PAK signaling pathways have opposing effects on the cell-to-cell spread of Marek's Disease Virus. 2012 PLoS ONE pmid:22952878
Knapp M et al. Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat. 2012 Basic Res. Cardiol. pmid:22961594
Taub DD et al. Distinct energy requirements for human memory CD4 T-cell homeostatic functions. 2013 FASEB J. pmid:22972918
Ratajczak MZ et al. An emerging link in stem cell mobilization between activation of the complement cascade and the chemotactic gradient of sphingosine-1-phosphate. 2013 Jul-Aug Prostaglandins Other Lipid Mediat. pmid:22981511
Aoyagi T et al. The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesis. 2012 Lymphat Res Biol pmid:22984905
Xiang SY et al. Lysophospholipid receptor activation of RhoA and lipid signaling pathways. 2013 Biochim. Biophys. Acta pmid:22986288
Patel SA et al. Overexpression of the adiponectin receptor AdipoR1 in rat skeletal muscle amplifies local insulin sensitivity. 2012 Endocrinology pmid:22989629
Moon MH et al. Sphingosine-1-phosphate inhibits interleukin-1β-induced inflammation in human articular chondrocytes. 2012 Int. J. Mol. Med. pmid:22992945
Park TS and Goldberg IJ Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure. 2012 Heart Fail Clin pmid:22999245
Taniguchi M et al. Regulation of autophagy and its associated cell death by "sphingolipid rheostat": reciprocal role of ceramide and sphingosine 1-phosphate in the mammalian target of rapamycin pathway. 2012 J. Biol. Chem. pmid:23035115
Kawashima T et al. Contrary effects of sphingosine-1-phosphate on expression of α-smooth muscle actin in transforming growth factor β1-stimulated lung fibroblasts. 2012 Eur. J. Pharmacol. pmid:23041148
Brewer JW Phospholipids: "greasing the wheels" of humoral immunity. 2013 Biochim. Biophys. Acta pmid:23051607
Di Menna L et al. Fingolimod protects cultured cortical neurons against excitotoxic death. 2013 Pharmacol. Res. pmid:23073075
Sorci-Thomas MG and Thomas MJ High density lipoprotein biogenesis, cholesterol efflux, and immune cell function. 2012 Arterioscler. Thromb. Vasc. Biol. pmid:23077142
Véret J et al. Role of palmitate-induced sphingoid base-1-phosphate biosynthesis in INS-1 β-cell survival. 2013 Biochim. Biophys. Acta pmid:23085009
Fernández-Pisonero I et al. Lipopolysaccharide and sphingosine-1-phosphate cooperate to induce inflammatory molecules and leukocyte adhesion in endothelial cells. 2012 J. Immunol. pmid:23089395
Ma Y et al. Sphingosine-1-phosphate (S1P) mediates darkness-induced stomatal closure through raising cytosol pH and hydrogen peroxide (Hâ‚‚Oâ‚‚) levels in guard cells in Vicia faba. 2012 Sci China Life Sci pmid:23090064
Mendoza A et al. The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate. 2012 Cell Rep pmid:23103166
Gandy KA et al. Sphingosine 1-phosphate induces filopodia formation through S1PR2 activation of ERM proteins. 2013 Biochem. J. pmid:23106337
Huang J et al. Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway. 2013 Mol. Cell. Endocrinol. pmid:23127801
Wilkerson BA et al. Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1. 2012 J. Biol. Chem. pmid:23135269
Tar L and Vécsei L [Fingolimod therapy in multiple sclerosis--the issue of the pathomechanism]. 2012 Ideggyogy Sz pmid:23136726
Japtok L et al. Sphingosine 1-phosphate modulates antigen capture by murine Langerhans cells via the S1P2 receptor subtype. 2012 PLoS ONE pmid:23145172
Zhang L et al. A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis. 2012 J. Exp. Med. pmid:23148237
Qiao Y et al. Sphingosine 1-phosphate elicits proinflammatory responses in ARPE-19 cells. 2012 Invest. Ophthalmol. Vis. Sci. pmid:23150617
Pantoja M et al. Genetic elevation of sphingosine 1-phosphate suppresses dystrophic muscle phenotypes in Drosophila. 2013 Development pmid:23154413
Hla T et al. S1P and the birth of platelets. 2012 J. Exp. Med. pmid:23166370
Cartwright TA et al. Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers. 2013 J. Cereb. Blood Flow Metab. pmid:23168528
Cuvillier O [Sphingosine 1-phosphate receptors: from biology to physiopathology]. 2012 Med Sci (Paris) pmid:23171898
Kurek K et al. [Role of sphingolipids in digestive system]. 2012 Postepy Hig Med Dosw (Online) pmid:23175343
Takahashi K et al. Novel therapy for liver regeneration by increasing the number of platelets. 2013 Surg. Today pmid:23180116
Lidington D et al. Capitalizing on diversity: an integrative approach towards the multiplicity of cellular mechanisms underlying myogenic responsiveness. 2013 Cardiovasc. Res. pmid:23180720
Nagahashi M et al. Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network. 2013 FASEB J. pmid:23180825
Kager LM et al. Endogenous protein C has a protective role during Gram-negative pneumosepsis (melioidosis). 2013 J. Thromb. Haemost. pmid:23216621
Jiang LI et al. Regions on adenylyl cyclase VII required for selective regulation by the G13 pathway. 2013 Mol. Pharmacol. pmid:23229509
Park K et al. A novel role of a lipid species, sphingosine-1-phosphate, in epithelial innate immunity. 2013 Mol. Cell. Biol. pmid:23230267
Xu Y et al. Low sphingosine-1-phosphate impairs lung dendritic cells in cystic fibrosis. 2013 Am. J. Respir. Cell Mol. Biol. pmid:23239501
Evindar G et al. Exploring amino acids derivatives as potent, selective, and direct agonists of sphingosine-1-phosphate receptor subtype-1. 2013 Bioorg. Med. Chem. Lett. pmid:23245510
Billich A et al. Cellular assay for the characterization of sphingosine-1-phosphate lyase inhibitors. 2013 Anal. Biochem. pmid:23246729